Global Recombinant Erythropoietin Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Recombinant Erythropoietin Market Size 2017-2028

2.1.2 Recombinant Erythropoietin Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Recombinant Erythropoietin Segment by Type

2.2.1 rhEPO

2.2.2 Erythropoiesis-Stimulating Agents (ESA)

2.3 Recombinant Erythropoietin Market Size by Type

2.3.1 Recombinant Erythropoietin Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Recombinant Erythropoietin Market Size Market Share by Type (2017-2022)

2.4 Recombinant Erythropoietin Segment by Application

2.4.1 Chronic Kidney Disease

2.4.2 Cancer Related Anemia

2.4.3 Others

2.5 Recombinant Erythropoietin Market Size by Application

2.5.1 Recombinant Erythropoietin Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Recombinant Erythropoietin Market Size Market Share by Application (2017-2022)

3 Recombinant Erythropoietin Market Size by Player

3.1 Recombinant Erythropoietin Market Size Market Share by Players

3.1.1 Global Recombinant Erythropoietin Revenue by Players (2020-2022)

3.1.2 Global Recombinant Erythropoietin Revenue Market Share by Players (2020-2022)

3.2 Global Recombinant Erythropoietin Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Recombinant Erythropoietin by Regions

4.1 Recombinant Erythropoietin Market Size by Regions (2017-2022)

4.2 Americas Recombinant Erythropoietin Market Size Growth (2017-2022)

4.3 APAC Recombinant Erythropoietin Market Size Growth (2017-2022)

4.4 Europe Recombinant Erythropoietin Market Size Growth (2017-2022)

4.5 Middle East & Africa Recombinant Erythropoietin Market Size Growth (2017-2022)

5 Americas

5.1 Americas Recombinant Erythropoietin Market Size by Country (2017-2022)

5.2 Americas Recombinant Erythropoietin Market Size by Type (2017-2022)

5.3 Americas Recombinant Erythropoietin Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Recombinant Erythropoietin Market Size by Region (2017-2022)

6.2 APAC Recombinant Erythropoietin Market Size by Type (2017-2022)

6.3 APAC Recombinant Erythropoietin Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Recombinant Erythropoietin by Country (2017-2022)

7.2 Europe Recombinant Erythropoietin Market Size by Type (2017-2022)

7.3 Europe Recombinant Erythropoietin Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Recombinant Erythropoietin by Region (2017-2022)

8.2 Middle East & Africa Recombinant Erythropoietin Market Size by Type (2017-2022)

8.3 Middle East & Africa Recombinant Erythropoietin Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Recombinant Erythropoietin Market Forecast

10.1 Global Recombinant Erythropoietin Forecast by Regions (2023-2028)

10.1.1 Global Recombinant Erythropoietin Forecast by Regions (2023-2028)

10.1.2 Americas Recombinant Erythropoietin Forecast

10.1.3 APAC Recombinant Erythropoietin Forecast

10.1.4 Europe Recombinant Erythropoietin Forecast

10.1.5 Middle East & Africa Recombinant Erythropoietin Forecast

10.2 Americas Recombinant Erythropoietin Forecast by Country (2023-2028)

10.2.1 United States Recombinant Erythropoietin Market Forecast

10.2.2 Canada Recombinant Erythropoietin Market Forecast

10.2.3 Mexico Recombinant Erythropoietin Market Forecast

10.2.4 Brazil Recombinant Erythropoietin Market Forecast

10.3 APAC Recombinant Erythropoietin Forecast by Region (2023-2028)

10.3.1 China Recombinant Erythropoietin Market Forecast

10.3.2 Japan Recombinant Erythropoietin Market Forecast

10.3.3 Korea Recombinant Erythropoietin Market Forecast

10.3.4 Southeast Asia Recombinant Erythropoietin Market Forecast

10.3.5 India Recombinant Erythropoietin Market Forecast

10.3.6 Australia Recombinant Erythropoietin Market Forecast

10.4 Europe Recombinant Erythropoietin Forecast by Country (2023-2028)

10.4.1 Germany Recombinant Erythropoietin Market Forecast

10.4.2 France Recombinant Erythropoietin Market Forecast

10.4.3 UK Recombinant Erythropoietin Market Forecast

10.4.4 Italy Recombinant Erythropoietin Market Forecast

10.4.5 Russia Recombinant Erythropoietin Market Forecast

10.5 Middle East & Africa Recombinant Erythropoietin Forecast by Region (2023-2028)

10.5.1 Egypt Recombinant Erythropoietin Market Forecast

10.5.2 South Africa Recombinant Erythropoietin Market Forecast

10.5.3 Israel Recombinant Erythropoietin Market Forecast

10.5.4 Turkey Recombinant Erythropoietin Market Forecast

10.5.5 GCC Countries Recombinant Erythropoietin Market Forecast

10.6 Global Recombinant Erythropoietin Forecast by Type (2023-2028)

10.7 Global Recombinant Erythropoietin Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Amgen

11.1.1 Amgen Company Information

11.1.2 Amgen Recombinant Erythropoietin Product Offered

11.1.3 Amgen Recombinant Erythropoietin Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Amgen Main Business Overview

11.1.5 Amgen Latest Developments

11.2 Johnson & Johnson

11.2.1 Johnson & Johnson Company Information

11.2.2 Johnson & Johnson Recombinant Erythropoietin Product Offered

11.2.3 Johnson & Johnson Recombinant Erythropoietin Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Johnson & Johnson Main Business Overview

11.2.5 Johnson & Johnson Latest Developments

11.3 Kyowa Hakko Kirin

11.3.1 Kyowa Hakko Kirin Company Information

11.3.2 Kyowa Hakko Kirin Recombinant Erythropoietin Product Offered

11.3.3 Kyowa Hakko Kirin Recombinant Erythropoietin Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Kyowa Hakko Kirin Main Business Overview

11.3.5 Kyowa Hakko Kirin Latest Developments

11.4 Roche

11.4.1 Roche Company Information

11.4.2 Roche Recombinant Erythropoietin Product Offered

11.4.3 Roche Recombinant Erythropoietin Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Roche Main Business Overview

11.4.5 Roche Latest Developments

11.5 3SBio Group

11.5.1 3SBio Group Company Information

11.5.2 3SBio Group Recombinant Erythropoietin Product Offered

11.5.3 3SBio Group Recombinant Erythropoietin Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 3SBio Group Main Business Overview

11.5.5 3SBio Group Latest Developments

11.6 Celltrion, Inc

11.6.1 Celltrion, Inc Company Information

11.6.2 Celltrion, Inc Recombinant Erythropoietin Product Offered

11.6.3 Celltrion, Inc Recombinant Erythropoietin Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Celltrion, Inc Main Business Overview

11.6.5 Celltrion, Inc Latest Developments

11.7 Teva Pharmaceutical Industries Ltd

11.7.1 Teva Pharmaceutical Industries Ltd Company Information

11.7.2 Teva Pharmaceutical Industries Ltd Recombinant Erythropoietin Product Offered

11.7.3 Teva Pharmaceutical Industries Ltd Recombinant Erythropoietin Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Teva Pharmaceutical Industries Ltd Main Business Overview

11.7.5 Teva Pharmaceutical Industries Ltd Latest Developments

11.8 F. Hoffmann-La Roche Ltd

11.8.1 F. Hoffmann-La Roche Ltd Company Information

11.8.2 F. Hoffmann-La Roche Ltd Recombinant Erythropoietin Product Offered

11.8.3 F. Hoffmann-La Roche Ltd Recombinant Erythropoietin Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 F. Hoffmann-La Roche Ltd Main Business Overview

11.8.5 F. Hoffmann-La Roche Ltd Latest Developments

11.9 LG Life Sciences Ltd

11.9.1 LG Life Sciences Ltd Company Information

11.9.2 LG Life Sciences Ltd Recombinant Erythropoietin Product Offered

11.9.3 LG Life Sciences Ltd Recombinant Erythropoietin Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 LG Life Sciences Ltd Main Business Overview

11.9.5 LG Life Sciences Ltd Latest Developments

11.10 Biocon Limited

11.10.1 Biocon Limited Company Information

11.10.2 Biocon Limited Recombinant Erythropoietin Product Offered

11.10.3 Biocon Limited Recombinant Erythropoietin Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Biocon Limited Main Business Overview

11.10.5 Biocon Limited Latest Developments

11.11 Intas Pharmaceuticals Ltd

11.11.1 Intas Pharmaceuticals Ltd Company Information

11.11.2 Intas Pharmaceuticals Ltd Recombinant Erythropoietin Product Offered

11.11.3 Intas Pharmaceuticals Ltd Recombinant Erythropoietin Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Intas Pharmaceuticals Ltd Main Business Overview

11.11.5 Intas Pharmaceuticals Ltd Latest Developments

11.12 Sun Pharmaceutical Industries Ltd

11.12.1 Sun Pharmaceutical Industries Ltd Company Information

11.12.2 Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Product Offered

11.12.3 Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Sun Pharmaceutical Industries Ltd Main Business Overview

11.12.5 Sun Pharmaceutical Industries Ltd Latest Developments

11.13 Dr. Reddy's Laboratories Ltd

11.13.1 Dr. Reddy's Laboratories Ltd Company Information

11.13.2 Dr. Reddy's Laboratories Ltd Recombinant Erythropoietin Product Offered

11.13.3 Dr. Reddy's Laboratories Ltd Recombinant Erythropoietin Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Dr. Reddy's Laboratories Ltd Main Business Overview

11.13.5 Dr. Reddy's Laboratories Ltd Latest Developments

12 Research Findings and Conclusion

Table 1. Recombinant Erythropoietin Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of rhEPO

Table 3. Major Players of Erythropoiesis-Stimulating Agents (ESA)

Table 4. Recombinant Erythropoietin Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 5. Global Recombinant Erythropoietin Market Size by Type (2017-2022) & ($ Millions)

Table 6. Global Recombinant Erythropoietin Market Size Market Share by Type (2017-2022)

Table 7. Recombinant Erythropoietin Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Recombinant Erythropoietin Market Size by Application (2017-2022) & ($ Millions)

Table 9. Global Recombinant Erythropoietin Market Size Market Share by Application (2017-2022)

Table 10. Global Recombinant Erythropoietin Revenue by Players (2020-2022) & ($ Millions)

Table 11. Global Recombinant Erythropoietin Revenue Market Share by Player (2020-2022)

Table 12. Recombinant Erythropoietin Key Players Head office and Products Offered

Table 13. Recombinant Erythropoietin Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 14. New Products and Potential Entrants

Table 15. Mergers & Acquisitions, Expansion

Table 16. Global Recombinant Erythropoietin Market Size by Regions 2017-2022 & ($ Millions)

Table 17. Global Recombinant Erythropoietin Market Size Market Share by Regions (2017-2022)

Table 18. Americas Recombinant Erythropoietin Market Size by Country (2017-2022) & ($ Millions)

Table 19. Americas Recombinant Erythropoietin Market Size Market Share by Country (2017-2022)

Table 20. Americas Recombinant Erythropoietin Market Size by Type (2017-2022) & ($ Millions)

Table 21. Americas Recombinant Erythropoietin Market Size Market Share by Type (2017-2022)

Table 22. Americas Recombinant Erythropoietin Market Size by Application (2017-2022) & ($ Millions)

Table 23. Americas Recombinant Erythropoietin Market Size Market Share by Application (2017-2022)

Table 24. APAC Recombinant Erythropoietin Market Size by Region (2017-2022) & ($ Millions)

Table 25. APAC Recombinant Erythropoietin Market Size Market Share by Region (2017-2022)

Table 26. APAC Recombinant Erythropoietin Market Size by Type (2017-2022) & ($ Millions)

Table 27. APAC Recombinant Erythropoietin Market Size Market Share by Type (2017-2022)

Table 28. APAC Recombinant Erythropoietin Market Size by Application (2017-2022) & ($ Millions)

Table 29. APAC Recombinant Erythropoietin Market Size Market Share by Application (2017-2022)

Table 30. Europe Recombinant Erythropoietin Market Size by Country (2017-2022) & ($ Millions)

Table 31. Europe Recombinant Erythropoietin Market Size Market Share by Country (2017-2022)

Table 32. Europe Recombinant Erythropoietin Market Size by Type (2017-2022) & ($ Millions)

Table 33. Europe Recombinant Erythropoietin Market Size Market Share by Type (2017-2022)

Table 34. Europe Recombinant Erythropoietin Market Size by Application (2017-2022) & ($ Millions)

Table 35. Europe Recombinant Erythropoietin Market Size Market Share by Application (2017-2022)

Table 36. Middle East & Africa Recombinant Erythropoietin Market Size by Region (2017-2022) & ($ Millions)

Table 37. Middle East & Africa Recombinant Erythropoietin Market Size Market Share by Region (2017-2022)

Table 38. Middle East & Africa Recombinant Erythropoietin Market Size by Type (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Recombinant Erythropoietin Market Size Market Share by Type (2017-2022)

Table 40. Middle East & Africa Recombinant Erythropoietin Market Size by Application (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Recombinant Erythropoietin Market Size Market Share by Application (2017-2022)

Table 42. Key Market Drivers & Growth Opportunities of Recombinant Erythropoietin

Table 43. Key Market Challenges & Risks of Recombinant Erythropoietin

Table 44. Key Industry Trends of Recombinant Erythropoietin

Table 45. Global Recombinant Erythropoietin Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 46. Global Recombinant Erythropoietin Market Size Market Share Forecast by Regions (2023-2028)

Table 47. Global Recombinant Erythropoietin Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 48. Global Recombinant Erythropoietin Market Size Market Share Forecast by Type (2023-2028)

Table 49. Global Recombinant Erythropoietin Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 50. Global Recombinant Erythropoietin Market Size Market Share Forecast by Application (2023-2028)

Table 51. Amgen Details, Company Type, Recombinant Erythropoietin Area Served and Its Competitors

Table 52. Amgen Recombinant Erythropoietin Product Offered

Table 53. Amgen Recombinant Erythropoietin Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 54. Amgen Main Business

Table 55. Amgen Latest Developments

Table 56. Johnson & Johnson Details, Company Type, Recombinant Erythropoietin Area Served and Its Competitors

Table 57. Johnson & Johnson Recombinant Erythropoietin Product Offered

Table 58. Johnson & Johnson Main Business

Table 59. Johnson & Johnson Recombinant Erythropoietin Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 60. Johnson & Johnson Latest Developments

Table 61. Kyowa Hakko Kirin Details, Company Type, Recombinant Erythropoietin Area Served and Its Competitors

Table 62. Kyowa Hakko Kirin Recombinant Erythropoietin Product Offered

Table 63. Kyowa Hakko Kirin Main Business

Table 64. Kyowa Hakko Kirin Recombinant Erythropoietin Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 65. Kyowa Hakko Kirin Latest Developments

Table 66. Roche Details, Company Type, Recombinant Erythropoietin Area Served and Its Competitors

Table 67. Roche Recombinant Erythropoietin Product Offered

Table 68. Roche Main Business

Table 69. Roche Recombinant Erythropoietin Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 70. Roche Latest Developments

Table 71. 3SBio Group Details, Company Type, Recombinant Erythropoietin Area Served and Its Competitors

Table 72. 3SBio Group Recombinant Erythropoietin Product Offered

Table 73. 3SBio Group Main Business

Table 74. 3SBio Group Recombinant Erythropoietin Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 75. 3SBio Group Latest Developments

Table 76. Celltrion, Inc Details, Company Type, Recombinant Erythropoietin Area Served and Its Competitors

Table 77. Celltrion, Inc Recombinant Erythropoietin Product Offered

Table 78. Celltrion, Inc Main Business

Table 79. Celltrion, Inc Recombinant Erythropoietin Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 80. Celltrion, Inc Latest Developments

Table 81. Teva Pharmaceutical Industries Ltd Details, Company Type, Recombinant Erythropoietin Area Served and Its Competitors

Table 82. Teva Pharmaceutical Industries Ltd Recombinant Erythropoietin Product Offered

Table 83. Teva Pharmaceutical Industries Ltd Main Business

Table 84. Teva Pharmaceutical Industries Ltd Recombinant Erythropoietin Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 85. Teva Pharmaceutical Industries Ltd Latest Developments

Table 86. F. Hoffmann-La Roche Ltd Details, Company Type, Recombinant Erythropoietin Area Served and Its Competitors

Table 87. F. Hoffmann-La Roche Ltd Recombinant Erythropoietin Product Offered

Table 88. F. Hoffmann-La Roche Ltd Main Business

Table 89. F. Hoffmann-La Roche Ltd Recombinant Erythropoietin Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 90. F. Hoffmann-La Roche Ltd Latest Developments

Table 91. LG Life Sciences Ltd Details, Company Type, Recombinant Erythropoietin Area Served and Its Competitors

Table 92. LG Life Sciences Ltd Recombinant Erythropoietin Product Offered

Table 93. LG Life Sciences Ltd Main Business

Table 94. LG Life Sciences Ltd Recombinant Erythropoietin Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 95. LG Life Sciences Ltd Latest Developments

Table 96. Biocon Limited Details, Company Type, Recombinant Erythropoietin Area Served and Its Competitors

Table 97. Biocon Limited Recombinant Erythropoietin Product Offered

Table 98. Biocon Limited Main Business

Table 99. Biocon Limited Recombinant Erythropoietin Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 100. Biocon Limited Latest Developments

Table 101. Intas Pharmaceuticals Ltd Details, Company Type, Recombinant Erythropoietin Area Served and Its Competitors

Table 102. Intas Pharmaceuticals Ltd Recombinant Erythropoietin Product Offered

Table 103. Intas Pharmaceuticals Ltd Recombinant Erythropoietin Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 104. Intas Pharmaceuticals Ltd Main Business

Table 105. Intas Pharmaceuticals Ltd Latest Developments

Table 106. Sun Pharmaceutical Industries Ltd Details, Company Type, Recombinant Erythropoietin Area Served and Its Competitors

Table 107. Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Product Offered

Table 108. Sun Pharmaceutical Industries Ltd Main Business

Table 109. Sun Pharmaceutical Industries Ltd Recombinant Erythropoietin Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 110. Sun Pharmaceutical Industries Ltd Latest Developments

Table 111. Dr. Reddy's Laboratories Ltd Details, Company Type, Recombinant Erythropoietin Area Served and Its Competitors

Table 112. Dr. Reddy's Laboratories Ltd Recombinant Erythropoietin Product Offered

Table 113. Dr. Reddy's Laboratories Ltd Main Business

Table 114. Dr. Reddy's Laboratories Ltd Recombinant Erythropoietin Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 115. Dr. Reddy's Laboratories Ltd Latest Developments

List of Figures

Figure 1. Recombinant Erythropoietin Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Recombinant Erythropoietin Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Recombinant Erythropoietin Market Size Market Share by Type in 2021

Figure 7. Recombinant Erythropoietin in Chronic Kidney Disease

Figure 8. Global Recombinant Erythropoietin Market: Chronic Kidney Disease (2017-2022) & ($ Millions)

Figure 9. Recombinant Erythropoietin in Cancer Related Anemia

Figure 10. Global Recombinant Erythropoietin Market: Cancer Related Anemia (2017-2022) & ($ Millions)

Figure 11. Recombinant Erythropoietin in Others

Figure 12. Global Recombinant Erythropoietin Market: Others (2017-2022) & ($ Millions)

Figure 13. Global Recombinant Erythropoietin Market Size Market Share by Application in 2021

Figure 14. Global Recombinant Erythropoietin Revenue Market Share by Player in 2021

Figure 15. Global Recombinant Erythropoietin Market Size Market Share by Regions (2017-2022)

Figure 16. Americas Recombinant Erythropoietin Market Size 2017-2022 ($ Millions)

Figure 17. APAC Recombinant Erythropoietin Market Size 2017-2022 ($ Millions)

Figure 18. Europe Recombinant Erythropoietin Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa Recombinant Erythropoietin Market Size 2017-2022 ($ Millions)

Figure 20. Americas Recombinant Erythropoietin Value Market Share by Country in 2021

Figure 21. Americas Recombinant Erythropoietin Consumption Market Share by Type in 2021

Figure 22. Americas Recombinant Erythropoietin Market Size Market Share by Application in 2021

Figure 23. United States Recombinant Erythropoietin Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada Recombinant Erythropoietin Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico Recombinant Erythropoietin Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil Recombinant Erythropoietin Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC Recombinant Erythropoietin Market Size Market Share by Region in 2021

Figure 28. APAC Recombinant Erythropoietin Market Size Market Share by Application in 2021

Figure 29. China Recombinant Erythropoietin Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan Recombinant Erythropoietin Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea Recombinant Erythropoietin Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia Recombinant Erythropoietin Market Size Growth 2017-2022 ($ Millions)

Figure 33. India Recombinant Erythropoietin Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia Recombinant Erythropoietin Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe Recombinant Erythropoietin Market Size Market Share by Country in 2021

Figure 36. Europe Recombinant Erythropoietin Market Size Market Share by Type in 2021

Figure 37. Europe Recombinant Erythropoietin Market Size Market Share by Application in 2021

Figure 38. Germany Recombinant Erythropoietin Market Size Growth 2017-2022 ($ Millions)

Figure 39. France Recombinant Erythropoietin Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK Recombinant Erythropoietin Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy Recombinant Erythropoietin Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia Recombinant Erythropoietin Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa Recombinant Erythropoietin Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa Recombinant Erythropoietin Market Size Market Share by Type in 2021

Figure 45. Middle East & Africa Recombinant Erythropoietin Market Size Market Share by Application in 2021

Figure 46. Egypt Recombinant Erythropoietin Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa Recombinant Erythropoietin Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel Recombinant Erythropoietin Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey Recombinant Erythropoietin Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country Recombinant Erythropoietin Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas Recombinant Erythropoietin Market Size 2023-2028 ($ Millions)

Figure 52. APAC Recombinant Erythropoietin Market Size 2023-2028 ($ Millions)

Figure 53. Europe Recombinant Erythropoietin Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa Recombinant Erythropoietin Market Size 2023-2028 ($ Millions)

Figure 55. United States Recombinant Erythropoietin Market Size 2023-2028 ($ Millions)

Figure 56. Canada Recombinant Erythropoietin Market Size 2023-2028 ($ Millions)

Figure 57. Mexico Recombinant Erythropoietin Market Size 2023-2028 ($ Millions)

Figure 58. Brazil Recombinant Erythropoietin Market Size 2023-2028 ($ Millions)

Figure 59. China Recombinant Erythropoietin Market Size 2023-2028 ($ Millions)

Figure 60. Japan Recombinant Erythropoietin Market Size 2023-2028 ($ Millions)

Figure 61. Korea Recombinant Erythropoietin Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia Recombinant Erythropoietin Market Size 2023-2028 ($ Millions)

Figure 63. India Recombinant Erythropoietin Market Size 2023-2028 ($ Millions)

Figure 64. Australia Recombinant Erythropoietin Market Size 2023-2028 ($ Millions)

Figure 65. Germany Recombinant Erythropoietin Market Size 2023-2028 ($ Millions)

Figure 66. France Recombinant Erythropoietin Market Size 2023-2028 ($ Millions)

Figure 67. UK Recombinant Erythropoietin Market Size 2023-2028 ($ Millions)

Figure 68. Italy Recombinant Erythropoietin Market Size 2023-2028 ($ Millions)

Figure 69. Russia Recombinant Erythropoietin Market Size 2023-2028 ($ Millions)

Figure 70. Spain Recombinant Erythropoietin Market Size 2023-2028 ($ Millions)

Figure 71. Egypt Recombinant Erythropoietin Market Size 2023-2028 ($ Millions)

Figure 72. South Africa Recombinant Erythropoietin Market Size 2023-2028 ($ Millions)

Figure 73. Israel Recombinant Erythropoietin Market Size 2023-2028 ($ Millions)

Figure 74. Turkey Recombinant Erythropoietin Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries Recombinant Erythropoietin Market Size 2023-2028 ($ Millions)